2022年度

Iwamoto A, Tsukamoto H, Nakayama H, Oshiumi H
E3 Ubiquitin Ligase Riplet Is Expressed in T Cells and Suppresses T Cell-Mediated Antitumor Immune Responses.
J Immunol. 2022 Apr 15;208(8):2067-2076.

Suzuki H, Abe R, Shimada M, Hirose T, Hirose H, Noguchi K, Ike Y, Yasui N, Furugori K, Yamaguchi Y, Toyoda A, Suzuki Y, Yamamoto T, Saitoh N, Sato S, Tomomori-Sato C, Conaway RC, Conaway JW, Takahashi H.
The 3' Pol II pausing at replication-dependent histone genes is regulated by Mediator through Cajal bodies' association with histone locus bodies.
Nat Commun. 2022 May 25;13(1):2905.

Tanaka T, Imamura T, Irie A, Yoneda M, Imamura R, Kikuchi K, Kitagawa S, Kubo T, Ogi H, Nakayama H.
Association of high cellular expression and plasma concentration of angiopoietin-like 4 with tongue cancer lung metastasis and poor prognosis.
Oncol Lett. 2022 Jul 5;24(3):299.

Minamitake A, Murakami R, Shiraishi S, Yoshida R, Sakata J, Hirosue A, Kawahara K, Yamana K, Nakayama H, Kitajima M, Sakamoto F.
Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
Oral Radiol. 2022 Jul;38(3):438-442.

Yakita M，Chujo T，Fan-Yan Wei，Hirayama M，Kato K，Takahashi N，Naganuma K，Nagata M，Kawahara K，Nakayama H，Tomizawa K.
Extracellular N 6-isopentenyladenosine (i6 A) addition induces cotranscriptional i6 A incorporation into ribosomal.
RNA. 2022 Jul;28(7):1013-1027.

Matsuoka Y, Yoshida R, Kawahara K, Sakata J, Arita H, Nkashima H, Takahashi N, Hirayama M, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Toya R, Murakami R, Nakayama H.
The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation.
Lab Invest. 2022 Aug;102(8):896-907.

Yamakawa N, Umeda M, Yoshii Y, Mitsudo K, Noguchi M, Kusukawa J, Katakura A, Nakayama H, Sasaki M, Noguchi T, Ueda M, Bukawa H, Yagihara K, Horie A, Miyazaki A, Chikazu D, Tomihara K, Mishima K, Otsuru M, Asoda S, Fujiwara S, Ohyama Y, Kurita H, Kawamata H, Fukuda M, Shintani Y, Kobayashi T, Kanno T, Oh-Iwa I, Kawano K, Yamashita Y, Kobayashi W, Ohiro Y, Uzawa K, Ota Y, Kirita T.
Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma.
Oral Dis. 2022 Dec 15. doi: 10.1111/odi.14471. Online ahead of print.

Kawaguchi S, Kawahara K, Fujiwara Y, Ohnishi K, Pan C, Yano H, Hirosue A, Nagata M, Hirayama M, Sakata J, Nakashima H, Arita H, Yamana K, Gohara S, Nagao Y, Maeshiro M, Iwamoto A, Hirayama M, Yoshida R, Komohara Y, Nakayama H. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration. Cancer Immunol Immunother. 2022 Sep;71(9):2127-2139.

Yanamoto S, Michi Y, Otsuru M, Inomata T, Nakayama H, Nomura T, Hasegawa T, Yamamura Y, Yamada SI, Kusukawa J, Yamakawa N, Hasegawa O, Ueda M, Kitagawa Y, Hiraki A, Hasegawa T, Ohiro Y, Kobayashi W, Asoda S, Kobayashi T, Iino M, Fukuda M, Ishibashi-Kanno N, Kawaguchi K, Aijima R, Noguchi K, Okura M, Tanaka A, Sugiura T, Shintani Y, Yagihara K, Yamashiro M, Ota Y, Miyazaki A, Takeshita A, Kawamata H, Hiroshi I, Uchida K, Umeda M, Kurita H, Kirita T.
Protocol for a multicentre, prospective observational study of elective neck dissection for clinically node-negative oral tongue squamous cell carcinoma (END-TC study).
BMJ Open. 2022 Sep 13;12(9):e059615.

Maynard S, Hall A, Galanos P, Rizza S, Yamamoto T, Gram HH, Munk SHN, Shoaib M, Sørensen CS, Bohr VA, Lerdrup M, Maya-Mendoza A, Bartek J.
Lamin A/C impairments cause mitochondrial dysfunction by attenuating PGC1α and the NAMPT-NAD+ pathway.
Nucleic Acids Res. 2022 Sep 23;50(17):9948-9965.

Kojima T, Yuno A, Hirayama M, Fukuma D, Shinohara M, Nishimura Y, Nakayama H.
Development of HLA-modified induced pluripotent stem cell-derived dendritic cells for a novel cancer immunotherapy.
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology Volume 34, Issue 5, September 2022, Pages 643-652

Gohara S, Shinohara K, Yoshida R, Kariya R, Tazawa H, Hashimoto M, Inoue J, Kubo R, Nakashima H, Arita H, Kawaguchi S, Yamana K, Nagao Y, Iwamoto A, Sakata J, Matsuoka Y, Takeshita H, Hirayama M, Kawahara K, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Okada S, Urata Y, Fujiwara T, Nakayama H.
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma.
Mol Ther Oncolytics. 2022 Oct 8:27:141-156.

Kanemaru A, Shinriki S, Kai M, Tsurekawa K, Ozeki K, Uchino S, Suenaga N, Yonemaru K, Miyake S, Masuda T, Kariya R, Okada S, Takeshita H, Seki Y, Yoshida R, Nakayama H, Li JD, Saito H.
Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance.
Cancer Cell Int. 2022 Nov 15;22(1):358.

Shinriki S, Hirayama M, Nagamachi A, Yokoyama A, Kawamura T, Kanai A, Kawai H, Iwakiri J, Liu R, Maeshiro M, Tungalag S, Tasaki M, Ueda M, Tomizawa K, Kataoka N, Ideue T, Suzuki Y, Asai K, Tani T, Inaba T, Matsui H.
DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cells.
Leukemia. 2022 Nov;36(11):2605-2620.

Hirayama M，Inoue K，Arita H，Takahashi N，Nakashima H，Sakata J，Maeshiro M，Nagao Y，Gohara S，Yamana K，Matsuoka Y，Yuno A，Nakamoto M，Kawahara K，Nagata M，Hirosue A，Fukuma D，Yoshida R，Nakayama H.
Three-dimensional volumetric analysis of the efficiency of marsupialization in patients with mandibular dentigerous cysts involving impacted third molars.
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology Volume 34, Issue 6, November 2022, Pages 690-697

Pegna, G. J., M. J. Lee, C. J. Peer, M. I. Ahmad, D. J. Venzon, Y. Yu, A. Yuno, S. M. Steinberg, L. Cao, W. D. Figg, R. N. Donahue, R. Hassan, I. Pastan, J. B. Trepel and C. Alewine.
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel.